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Purpose/Objective: 4D-CBCT provides the potential for 
significant improvements in patient treatment, but must be 
smoothly integrated into the clinical workflow both to 
optimize the treatment process for the patient and to ensure 
patient safety. Following the installation of 4D-CBCT an 
implementation process and preliminary clinical evaluation of 
4D-CBCT has been performed. A multi-professional team has 
been involved in the implementation and evaluation process.  
Materials and Methods: 4D-CBCT scans have been acquired 
on patients planned using 4D-CT (p4D-CT) data over a 12-
month period. A process was developed for the on-line 3D-
CBCT registration, 4D-CBCT retrospective reconstruction and 
viewing of 4D-CBCT image data in comparison with p4D-CT 
image data. All steps in the process were evaluated to 
develop a method integrated with the RTT’s clinical linac 
workflow. This included image acquisition, reconstruction 
and assessment of image quality. To assist with patient 
selection for 4D-CBCT and departmental resource restrictions 
the tumour motion on p4D-CT data was compared to 4D-CBCT 
treatment data and any changes in tumour motion, size or 
position noted. 
Results: 4D-CBCT scans were acquired on 60 conventionally 
fractionated lung, 62 SABR lung, 33 oesophagus, 4 expiration 
gated lung, 1 SABR liver and 3 abdominal patients. The total 
number of 4D-CBCT scans was 411. The 4D-CBCT 
reconstruction time of 3 min is quick enough for near online 
image review but is not feasible with the patient on the 
treatment couch in a busy department. Treatment RTTs 
required additional training for the data export and 
reconstruction processes and a training package has been 
written. Image quality is felt to be acceptable for verification 
purposes of thoracic tumours. There is a requirement to 
optimise the 4D-CBCT acquisition parameters to improve 
image quality for abdominal tumours. 2 patients were re-
planned based on the assessment of tumour motion on the 
4D-CBCT data compared to the p4D-CT data. For other 
patients, 4D-CBCT was a useful tool to verify tumour motion 
between planning and treatment. It was especially useful for 
gated patient verification where the relationship between 
the external surrogate and tumour motion may change 
between planning and treatment.  
Conclusions: It is beneficial to utilise 4D-CBCT to verify any 
lung treatment involving anatomical motion due to 
respiration, whether a respiratory gated treatment is used or 
not. 4D-CBCT is felt to be essential for the verification of 
gated treatments and may enable an increased number of 
patients to receive a gated treatment as it may remove the 
reliance on the tumour being visible on fluoroscopy. We are 
continuing to optimise imaging modes for abdominal 4D-CBCT 
scans and clinical applications. A training program has been 
developed for RTTs to perform the evaluation of the 4D-CBCT 
image data and is fully integrated into the routine clinical 
workflow. 
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Purpose/Objective: A 2D ultrasound (US) probe has recently 
being applied as a tool for image guided radiotherapy (IGRT), 
despite reported challenges in the probe handling. The aim 
of this study was to investigate a novel 3D-US probe against 
the conventional 2D probe for gynecological (GYN) IGRT. 
Materials and Methods: 9 healthy volunteers were US-
scanned by 6 operators (RTTs), using both 2D and 3D probes 
(Clarity® Model 310C00, Elekta, Montreal, Canada) (see 
figure). 
  
 
In total, 38 US-scans were performed. Two observers 
(Physicist and RTT) were evaluating the image quality, and, 
independently, delineated the uterus on all scans. The image 
quality was classified from 1-10, where 10 was perceived as 
excellent. Furthermore, the uterus in the acquired images 
was divided in 4 sections. This scale was introduced to, 
quantitatively, evaluate the capacity of each probe in 
capturing the whole uterine volume. For instance, 4 uterine 
visible sections was indicating capture of entire uterus and 2 
sections, on the other hand, means that half of the uterine 
volume is imaged. 
Results: Using the 2D probe yielded a mean image quality of 
5.4 (mean of 38 scans and two observers). The 3D probe 
resulted in a mean of 7.2, implying a better image quality. 
Furthermore, uterine capture using the 2D and the 3D probe 
resulted in a mean of 2.9 and 3.6, respectively. All observers 
were concordant in preferring the 3D-probe over the 2D-
probe images for uterine delineation, due to better image 
quality. Secondly, the uterine capture was readily achievable 
using the 3D probe as compared to the 2D probe. 
Furthermore, during image acquisition, the 2D probe required 
a manual handling, known as sweep slide-technique, which 
was experienced to be challenging for all the RTTs. Inversely, 
the 3D probe is a semi-automatic imaging system, meaning 
that the images could be acquired by initially identifying the 
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uterus in sagittal plane and, afterwards, utilizing the 
automatic ultrasound array to sweep over the region of 
interest. 
Conclusions: The quality of the ultrasound images using the 
3D probe was superior to the images of the 2D probe. 
Moreover, the uterine capture, using the 3D probe required 
less effort than the cumbersome 2D probe. In summary, the 
3D probe is a user-friendly and promising alternative as an 
IGRT system for GYN patients in radiotherapy. 
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Purpose/Objective: DIBH can reduce heart dose when 
planning breast RT versus free breathing. Whilst reducing 
heart dose is an important clinical objective, DIBH must 
support accurate and reproducible treatment. Inspired lung 
volume (VInsp) variation was considered an important variable 
in terms of the impact on set-up accuracy in the DIBH 
setting. The Varian Real Time Position Management system 
(RPM) uses a reflective marker block that when positioned on 
the patient acts as a respiratory surrogate. The aim of this 
study was to measure the variation of VInsp when performing 
DIBH with the Varian RPM over a treatment course.  
Materials and Methods: 10 staff volunteers were positioned 
supine on a 15° inclined breast board with both arms raised. 
The RPM marker block was localised on midline where 
vertical movement was observed during DIBH coaching. Three 
DIBHs were acquired within a preparatory session and the 
largest amplitude selected to set the reference threshold. 
From this the volunteer was visually coached to acquire the 
reference DIBH, simulating a 'planning' CT. Each volunteer 
attended 8 subsequent 'treatment' sessions where they were 
visually coached to perform 3 DIBHs to the reference 
amplitude (5mm threshold). For all sessions, VInsp was 
measured with the SDX® DynR spirometer. Systematic and 
random error was calculated by analysing the mean and 
standard deviations of the VInsp for each individual and the 
entire cohort. Variation was measured as a percentage 
difference from the reference VInsp.  
Results: All volunteers performed 25 second DIBHs with 
minimal coaching, meeting their RPM amplitude (5mm 
threshold) for all sessions. Mean time between reference 
session and first treatment was 14.1 days (range 5 - 28). 
Mean time to acquire 8 treatment sessions was 72 days (range 
35 - 105). 10 reference and 240 treatment DIBH's were 
acquired. Mean reference RPM amplitude was 21.8mm (range 
12.2 - 32.2). Mean reference VInsp was 1.94 litres (range 1.41 - 
3.44). Mean total VInsp variation for treatment compared to 
the reference sessions for the population was 22% (range 0% – 
100%). The systematic error in VInsp between reference and 
treatment sessions for the population was 30% (individual 
systematic error varied from -25% to 74%) and random error 
between the reference and treatment sessions for the 
population was 14% (range 5% - 24%). The population mean 
was 1%, showing there was no systematic directional error in 
Vinsp for the cohort.  
 
 
 
Conclusions: DIBH with the Varian RPM is associated with a 
variation in the volume of air inspired over a treatment 
course and compared to the reference. The impact of this 
variation on the dose planned versus that delivered needs 
further prospective evaluation. Quantifying the dosimetric 
effect on the heart, lungs, tumour bed and ipsilateral breast 
when using the Varian RPM for DIBH breast radiotherapy is 
recommended. 
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Purpose/Objective: To assess suitability of lung margins 
following analysis of set up data from patients recruited 
within the Concurrent ONce-daily VErsus twice-daily 
RadioTherapy (CONVERT) Trial: A 2-arm randomised 
controlled trial of concurrent chemo-radiotherapy comparing 
twice-daily and once-daily radiotherapy schedules in patients 
with limited stage small cell lung cancer (SCLC) and good 
performance status (grade 0 to grade 1). Margins outlined 
within the CONVERT trial define the clinical target volume 
(CTV) as the gross tumour volume (GTV) + 0.5cm in all 
directions and the planning target volume (PTV) as the CTV + 
0.8cm anterior-posterior (A/P) and left-right (L/R) plane, and 
1.0cm in the superior-inferior (S/I) plane. The impact of 
gender or immobilisation device on margins was also 
assessed. 
Materials and Methods: At this institution ninety patients 
were recruited, planned and treated within the CONVERT 
trial. Patients were treated supine, either with a 5 point 
immobilisation shell or with both arms positioned above their 
head on a lung board. Knee bolsters were used for added 
comfort. Cone Beam Computed Tomography (CBCT) images 
using Elekta Synergy TM – version 4.5 were acquired during 
treatment for the first 3 fractions and then at least weekly 
thereafter following a systematic error reduction strategy 
